isomethyleugenol has been researched along with Gliosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amano, T; Araki, Y; Iwaki, T; Mizoguchi, M; Nakamizo, A; Sasaki, T; Shono, T; Suzuki, SO; Yoshimoto, K | 1 |
| Jha, P; Joshi, N; Julka, PK; Kale, SS; Mahapatra, AK; Mallick, S; Purkait, S; Sarkar, C; Sharma, MC; Sharma, V; Singh, G; Singh, M; Suri, V | 1 |
2 other study(ies) available for isomethyleugenol and Gliosarcoma
| Article | Year |
|---|---|
Quantitative digital assessment of MGMT immunohistochemical expression in glioblastoma tissue.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Brain Neoplasms; DNA Modification Methylases; DNA Repair Enzymes; Female; Glioblastoma; Gliosarcoma; Humans; Immunohistochemistry; Male; Methylation; Middle Aged; Tumor Suppressor Proteins | 2011 |
A study of clinico-pathological parameters and O⁶-methylguanine DNA methyltransferase (MGMT) promoter methylation status in the prognostication of gliosarcoma.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; DNA; DNA Modification Methylases; DNA Repair Enzymes; Endpoint Determination; Female; Follow-Up Studies; Gliosarcoma; Humans; Immunohistochemistry; Karnofsky Performance Status; Male; Methylation; Middle Aged; Neurosurgical Procedures; Prognosis; Promoter Regions, Genetic; Survival; Survival Analysis; Tumor Suppressor Proteins; Young Adult | 2012 |